Yes. This compounded medication is dispensed by Strive Pharmacy pursuant to a valid prescription from a licensed provider following a telemedicine consultation.

Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort, particularly during the first few weeks as your body adjusts. These typically improve with continued use. Pancreatitis has been reported with GLP-1 therapy — stop use and contact your provider immediately if you experience persistent, severe abdominal pain. In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumors; the relevance to humans is not established, but this medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.

Not for use in patients with a history of medullary thyroid carcinoma or MEN 2. Not recommended during pregnancy or breastfeeding. Do not use alongside injectable semaglutide or other GLP-1 agonists.

Semaglutide may slow gastric emptying and affect absorption timing of other oral medications. Do not combine with other GLP-1 agonists. Disclose all medications to your provider before starting.

Not recommended for patients with severe gastrointestinal disease, active pancreatitis, or significant renal impairment. Eligibility is assessed by a licensed provider on a case-by-case basis.